(A) Comparison of the cumulative survival curves stratified with B-RTL (5 rfu, red line, and ≥ 4.6 x 105 rfu, blue line). (B) Comparison of the cumulative survival curves stratified with L-RTL (5 rfu, red line, and ≥ 2.7 x 105 rfu, blue line). (C) Comparison of the cumulative survival curves stratified with donor age (< 45 years old, red line, vs ≥ 45 years old, blue line). (D) Comparison of the cumulative survival curves stratified with MELD score (< 18, red line, and ≥ 18, blue line).</p
<p>These were obtained by applying nearest shrunken centroids to the DLBCL test data. Patients in th...
<p>Comparison of the 1- and 3- year survival rates among group LS, LN, HS, and HN (A); Excluding HCC...
(A) Comparison of death-censored graft survival rates between high and low KDPI KTR groups (P<0.001,...
<p>Survival curves of patients undergoing LDLT versus DDLT (<i>P</i> = 0.400).</p
<p>(<b>a</b>) Survival curves stratified by AJCC pN categories; (<b>b</b>) Survival curves stratifie...
<p>Relative survival curves of patients with CLL in different time periods in Taiwan: (A) for all pa...
<p>A) Overall graft survival in recipients from DM and non-DM donors. Recipients with DM donors had ...
<p>Recurrence-free survival (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0...
<p>Patients’ survival after LDLT and DDLT in the ALF group with the Kaplan-Meier comparison.</p
<p>The blue curve corresponds to the Kaplan-Meier survival curve for the entire population used to l...
<p>Kaplan-Meier analysis was used to compare survivals between patients underwent LDLT and those rec...
<p>There are significant differences in OS between LDLT/ DDLT recipients fulfilling Hangzhou criteri...
P-values were calculated by log-rank test. A. Recipient survival in the overall cohort; B. Graft sur...
<p><b>A,</b> Survival curves of patients with different sT categories. <b>B,</b> Survival curves of ...
<p>Comparison of the 1- and 3- year survival rates between group L and group H (A); Excluding HCC re...
<p>These were obtained by applying nearest shrunken centroids to the DLBCL test data. Patients in th...
<p>Comparison of the 1- and 3- year survival rates among group LS, LN, HS, and HN (A); Excluding HCC...
(A) Comparison of death-censored graft survival rates between high and low KDPI KTR groups (P<0.001,...
<p>Survival curves of patients undergoing LDLT versus DDLT (<i>P</i> = 0.400).</p
<p>(<b>a</b>) Survival curves stratified by AJCC pN categories; (<b>b</b>) Survival curves stratifie...
<p>Relative survival curves of patients with CLL in different time periods in Taiwan: (A) for all pa...
<p>A) Overall graft survival in recipients from DM and non-DM donors. Recipients with DM donors had ...
<p>Recurrence-free survival (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0...
<p>Patients’ survival after LDLT and DDLT in the ALF group with the Kaplan-Meier comparison.</p
<p>The blue curve corresponds to the Kaplan-Meier survival curve for the entire population used to l...
<p>Kaplan-Meier analysis was used to compare survivals between patients underwent LDLT and those rec...
<p>There are significant differences in OS between LDLT/ DDLT recipients fulfilling Hangzhou criteri...
P-values were calculated by log-rank test. A. Recipient survival in the overall cohort; B. Graft sur...
<p><b>A,</b> Survival curves of patients with different sT categories. <b>B,</b> Survival curves of ...
<p>Comparison of the 1- and 3- year survival rates between group L and group H (A); Excluding HCC re...
<p>These were obtained by applying nearest shrunken centroids to the DLBCL test data. Patients in th...
<p>Comparison of the 1- and 3- year survival rates among group LS, LN, HS, and HN (A); Excluding HCC...
(A) Comparison of death-censored graft survival rates between high and low KDPI KTR groups (P<0.001,...